Avanir Pharmaceuticals,Incorporation - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Avanir Pharmaceuticals,Incorporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Avanir Pharmaceuticals,Incorporation Formerly known as AVANIR Pharmaceuticals. The Group's principal activity is to develop, acquire and commercialize novel therapeutic products for the treatment of chronic diseases. The product candidate address therapeutic markets that include the central nervous system and inflammatory diseases. The product candidate Zenvia is in the phase III clinical development for the treatment of pseudobulbar affect and diabetic peripheral neuropathic pain. The Group also has an ongoing development program with Novartis for the treatment of inflammatory disease.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report